CLEARPOINT NEURO INC (CLPT)

US18507C1036 - Common Stock

5.87  +0.35 (+6.34%)

After market: 5.94 +0.07 (+1.19%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

CLEARPOINT NEURO INC

NASDAQ:CLPT (5/3/2024, 7:00:00 PM)

After market: 5.94 +0.07 (+1.19%)

5.87

+0.35 (+6.34%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap158.90M
Shares
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts
IPO
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

CLPT Daily chart

Company Profile

Clearpoint Neuro, Inc. engages in the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain and heart. The company is headquartered in Solana Beach, California and currently employs 108 full-time employees. The company went IPO on 2019-07-03. The firm develops and commercializes platforms for performing minimally invasive surgical procedures in the brain. Its ClearPoint system is an integrated system comprised of hardware components, disposable components and intuitive, menu-driven software. Its hardware components consist primarily of a head fixation frame, computer workstation, and in-room monitor. Its disposable components for its ClearPoint system consist primarily of its SmartFrame trajectory device, a hand controller and related accessories, and its SmartFlow Cannula. Its ClearPoint system software guides the physician in surgical planning, device alignment, navigation to the target and procedure monitoring. Its ClearPoint Prism Neuro Laser Therapy System is indicated for use to necrotize or coagulate soft tissue through interstitial irradiation or thermal therapy for neuro applications under 3.0T magnetic resonance imaging (MRI) guidance.

Company Info

CLEARPOINT NEURO INC

120 S. Sierra Avenue, Suite 100

Solana Beach CALIFORNIA 92618

P: 19499006833

CEO: Joseph M. Burnett

Employees: 108

Website: https://www.clearpointneuro.com/

CLPT News

News Image4 days ago - InvestorPlace7 Penny Stocks That Could Make You a Fortune (If You Dare)

These penny stocks offer robust operational opportunities amid wider economic and market concerns pushing weaker companies downward.

News Image18 days ago - ClearPoint Neuro, Inc.ClearPoint Neuro félicite son partenaire AviadoBio pour son premier patient traité dans le cadre de son essai clinique ASPIRE-FTD évaluant l’AVB-101 dans la démence fronto-temporale avec mutations du gène GRN

Les centres ASPIRE-FTD dans l’UE et aux États-Unis utiliseront la navigation ClearPoint® avec la canule SmartFlow® pour l’administration de thérapie...

News Image18 days ago - ClearPoint Neuro, Inc.ClearPoint Neuro beglückwünscht seinem Partner AviadoBio zur Behandlung des ersten Patienten in der klinischen Studie ASPIRE-FTD, in der AVB-101 für frontotemporale Demenz mit GRN-Mutationen evaluiert wird

Prüfzentren für ASPIRE-FTD in der EU und den USA verwenden ClearPoint® Navigation zusammen mit der SmartFlow®-Kanüle für die intrathalamische Gentherapie...

News Image18 days ago - ClearPoint Neuro, Inc.ClearPoint Neuro si congratula con il proprio partner AviadoBio per il primo paziente trattato nello studio clinico ASPIRE-FTD, che valuta la terapia genica sperimentale AVB-101 per la demenza frontotemporale con mutazioni GRN

I siti ASPIRE-FTD nell’UE e negli Stati Uniti utilizzeranno la navigazione ClearPoint® insieme alla cannula SmartFlow® per la somministrazione della...

News Image18 days ago - ClearPoint Neuro, Inc.ClearPoint Neuro felicita a su socio AviadoBio por el primer paciente tratado en su ensayo clínico ASPIRE-FTD que evalúa AVB-101 en personas con demencia frontotemporal con mutaciones en el gen GRN

Los centros ASPIRE-FTD de la UE y EE. UU. ...

News Image18 days ago - ClearPoint Neuro, Inc.ClearPoint Neuro feliciteert partner AviadoBio met de behandeling van de eerste patiënt in klinisch onderzoek ASPIRE-FTD, waarin AVB-101 wordt geëvalueerd voor frontotemporale dementie met GRN-mutaties

De onderzoekscentra van ASPIRE-FTD in de EU en de VS zullen gebruikmaken van ClearPoint® Navigation in combinatie met de SmartFlow® Cannula voor de...

CLPT Twits

Here you can normally see the latest stock twits on CLPT, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example